ID   FRTL-5/TA
AC   CVCL_A6IK
DR   Wikidata; Q107115081
RX   PubMed=1694496;
RX   PubMed=8761378;
CC   Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS:0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6IJ ! FRTL-5/T
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
RX   PubMed=1694496; DOI=10.1210/endo-127-1-419;
RA   Ossendorp F.A., Bruning P.F., Schuuring E.M.D., van den Brink J.A.M.,
RA   van der Heide D., de Vijlder J.J.M., de Bruin T.W.A.;
RT   "Thyrotropin dependent and independent thyroid cell lines selected
RT   from FRTL-5 derived tumors grown in nude mice.";
RL   Endocrinology 127:419-430(1990).
//
RX   PubMed=8761378; DOI=10.1038/bjc.1996.409; PMCID=PMC2074668;
RA   van der Kallen C.J.H., Coes J.H., van Grafhorst J.P., Schuuring E.M.D.,
RA   Ossendorp F.A., Thijssen J.H.H., Blankenstein M.A., de Bruin T.W.A.;
RT   "Dissociation of thyrotropin receptor function and thyrotropin
RT   dependency in rat thyroid tumour cell lines derived from FRTL-5.";
RL   Br. J. Cancer 74:606-612(1996).
//